92.91
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$92.08
Offen:
$92
24-Stunden-Volumen:
6.44M
Relative Volume:
0.85
Marktkapitalisierung:
$119.09B
Einnahmen:
$33.54B
Nettoeinkommen (Verlust:
$4.69B
KGV:
25.67
EPS:
3.62
Netto-Cashflow:
$5.19B
1W Leistung:
+3.97%
1M Leistung:
+3.33%
6M Leistung:
+0.77%
1J Leistung:
+12.93%
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Vergleichen Sie MDT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2024-08-21 | Bestätigt | Oppenheimer | Perform |
2024-08-15 | Hochstufung | UBS | Sell → Neutral |
2024-08-14 | Herabstufung | Stifel | Buy → Hold |
2024-05-30 | Eingeleitet | Goldman | Sell |
2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
2023-06-30 | Eingeleitet | CL King | Buy |
2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-03-29 | Herabstufung | UBS | Buy → Sell |
2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
2022-10-18 | Eingeleitet | Barclays | Equal Weight |
2022-10-13 | Eingeleitet | Mizuho | Buy |
2022-10-12 | Eingeleitet | Jefferies | Hold |
2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-05-27 | Herabstufung | Needham | Buy → Hold |
2022-04-13 | Herabstufung | Truist | Buy → Hold |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
2021-06-10 | Fortgesetzt | Cowen | Outperform |
2021-05-25 | Eingeleitet | Barclays | Equal Weight |
2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2020-10-08 | Hochstufung | Stifel | Hold → Buy |
2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
2020-03-05 | Eingeleitet | Citigroup | Buy |
2020-02-13 | Eingeleitet | Goldman | Sell |
2020-01-08 | Eingeleitet | SunTrust | Buy |
2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
2019-02-04 | Bestätigt | Needham | Strong Buy |
2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
2018-11-28 | Eingeleitet | UBS | Buy |
2018-10-16 | Eingeleitet | Barclays | Overweight |
2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy? - The Globe and Mail
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk - uk.finance.yahoo.com
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is This a Bottoming Phase for Medtronic plcCapital Preserving Trade Plan Templates Shared - metal.it
Can Medtronic plc weather a recessionHigh Growth Alert System - kangso.co.kr
Daily Turnover | The turnover of Medtronic on 8/8 was $612.96 Million, Ranking 149 - AInvest
Neuro-Navigation Systems Market Set to Witness Significant Growth by 2025-2032 | Medtronic plc, Stryker - EIN News
Precision Trading with Medtronic Plc. (MDT) Risk Zones - news.stocktradersdaily.com
Medtronic Bets On Growth And Focus With Diabetes Spin-Off - Finimize
Medtronic (MDT) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Medtronic to Report Q1 FY2026 Results Eyes Momentum in Global Markets - MSN
Medtronic (MDT) Stock Growth & Analyst Outlook 2024News and Statistics - IndexBox
Medtronic Stock Analyst Sentiment: Analysts Bullish on MDT Despite Recent Surge - AInvest
Are Wall Street Analysts Bullish on Medtronic Stock? - Yahoo Finance
Those who invested in Medtronic (NYSE:MDT) a year ago are up 15% - simplywall.st
Medtronic, FMMC join forces to enhance surgical training in laparoscopic, hernia procedures - Daijiworld
Medtronic to Report Q1 FY2026 Results, Eyes Momentum in Global MarketsVietnam Investment Review - Vietnam Investment Review - VIR
Medtronic to announce financial results for its first quarter of fiscal year 2026 - Laotian Times
Medtronic Announces Q1 FY 2026 Earnings on August 19, 2025 - AInvest
Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again - Yahoo Finance
United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka - Yahoo Finance
Bernstein Adjusts Price Target on Medtronic to $97 From $93, Maintains Outperform Rating - MarketScreener
Medtronic (MDT) Invests in Orchestra BioMed's Strategic Expansion - GuruFocus
Medtronic: Diabetes Business Spin-Off Key To Overcoming Stagnation (NYSE:MDT) - Seeking Alpha
Medtronic gets EU nod for MiniMed 780G System - MSN
What are analysts’ price targets for Medtronic plc in the next 12 monthsMaximize gains with data-driven trading alerts - Jammu Links News
Medtronic plc Stock Analysis and ForecastInvest like a pro with expert recommendations - Jammu Links News
When is Medtronic plc stock expected to show significant growthAchieve rapid financial growth with smart picks - Jammu Links News
How does Medtronic plc generate profit in a changing economyInvest confidently with expert support - Jammu Links News
What markets is GDRX expanding into Is Medtronic plc stock a good long term investment optionUnlock powerful trading tools for investors - Jammu Links News
What are the technical indicators suggesting about Medtronic plcBuild a diversified portfolio for steady growth - jammulinksnews.com
How many analysts rate Medtronic plc as a “Buy”Get professional guidance for market timing - Jammu Links News
What is Medtronic plc company’s growth strategyNavigate market shifts with confidence - Jammu Links News
What institutional investors are buying Medtronic plc stockFree Stock Market Beginners Guide - Jammu Links News
What drives Medtronic plc stock priceInvest confidently with real-time updates - Jammu Links News
Should I hold or sell Medtronic plc stock in 2025Maximize your returns with smart trade entries - Jammu Links News
Medtronic plc stock outlook for YEARFast Exit and Entry Strategy Guide Offered - metal.it
What are Medtronic plc company’s key revenue driversAmplify your gains with low-risk picks - Jammu Links News
Medtronic’s Long-term Cardiac Device Study: Implications for Investors - The Globe and Mail
Is Medtronic plc stock overvalued or undervaluedDaily Trading Alerts For Every Investor - jammulinksnews.com
Medtronic (MDT) Stock Moves -1.05%: What You Should Know - Yahoo Finance
Breakout Traders Target Medtronic plc on Recovery SetupFast Entry High Potential Stock Alerts Triggered - metal.it
Orchestra BioMed secures $70 million from Ligand and Medtronic By Investing.com - Investing.com UK
Ligand and Medtronic invest $70mln in Orchestra BioMed for AVIM therapy. - AInvest
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
Medtronic PLC (MDT) Shareholder Update: Hedge Funds Increase Holdings by 0.18% - AInvest
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):